Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Paeds SAQscardiology

Paeds SAQs · cardiology

Cyanotic newborn and critical congenital heart disease screening — formative SAQs

Formative SAQs on the cyanotic newborn and critical congenital heart disease screening: applying the pulse-oximetry thresholds, starting prostaglandin E1 before the echocardiogram, separating cyanotic congenital heart disease from pulmonary and sepsis mimics, and escalating to a cardiac centre.

20 marks30 min1 min readVerification in progress

Target exams

RACP General PaediatricsMRCPCH ClinicalRACP DWE
On this page
Study tools

Target exams

RACP General PaediatricsMRCPCH ClinicalRACP DWE
Prompt
Critical congenital heart disease screening and the cyanotic newborn

SAQ 1 (10)

A term infant born after an uncomplicated pregnancy is noted on the postnatal ward at thirty hours of age to be dusky during a feed but otherwise comfortable, with no respiratory distress. The midwife records a pulse oximetry of 86 per cent in the right hand and 84 per cent in the foot in air. There is no murmur. [2] [3]

a) Interpret these pulse-oximetry findings against the screening thresholds, and state the immediate next step. (2 marks) [2]

b) The baby is alert and looks well. Justify why this appearance does not lower your concern, and name the bedside examination findings that would localise a cardiac lesion. (3 marks) [2]

c) Outline your immediate management, naming the drug, the dose and the airway consideration, and explain why it precedes the echocardiogram. (3 marks) [8] [9]

d) The team asks whether to give 100 per cent oxygen while awaiting the team. Explain the principle that governs oxygen use in a suspected duct-dependent mixing lesion. (2 marks) [2]

Paediatrics Fellowship Pro

Continue reading

You have read the opening of this SAQ. The complete unit — every section and its primary-source references — is part of the Paediatrics Fellowship fellowship library.

Sign in to continueSee pricing
References5ShowHide
  1. [1]de-Wahl Granelli A, Wennergren M, Sandberg K, et al. Impact of pulse oximetry screening on the detection of duct dependent congenital heart disease: a Swedish prospective screening study in 39,821 newborns. BMJ, 2009.PMID 19131383
  2. [2]Mahle WT, Newburger JW, Matherne GP, et al. Role of pulse oximetry in examining newborns for congenital heart disease: a scientific statement from the American Heart Association and American Academy of Pediatrics. Circulation, 2009.PMID 19581492
  3. [3]Ewer AK, Middleton LJ, Furmston AT, et al. Pulse oximetry screening for congenital heart defects in newborn infants (PulseOx): a test accuracy study. Lancet, 2011.PMID 21820732
  4. [8]Aykanat A, Yavuz T, Özalkaya E, et al. Long-Term Prostaglandin E1 Infusion for Newborns with Critical Congenital Heart Disease. Pediatr Cardiol, 2016.PMID 26260095
  5. [9]Vari D, Xiao W, Behere S, et al. Low-dose prostaglandin E1 is safe and effective for critical congenital heart disease: is it time to revisit the dosing guidelines? Cardiol Young, 2021.PMID 33140712
Paediatrics Fellowship Pro

$29/ monthor $279 / year

The complete Paediatrics Fellowship library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousCongenital coronary anomalies and ALCAPA — formative SAQscardiologyNextDuct-dependent congenital heart disease: SAQcardiology